Literature DB >> 15785882

Long-term outcome of surgically treated Crohn's colitis: a prospective study.

Alessandro Fichera1, Richard McCormack, Michelle A Rubin, Roger D Hurst, Fabrizio Michelassi.   

Abstract

PURPOSE: Although bowel-sparing techniques have been published for treatment of Crohn's disease of the small bowel because of its relentless nature, extent of resection in Crohn's colitis is still a topic of debate. This study was designed to prospectively evaluate the long-term outcomes of patients with isolated Crohn's colitis to identify patients that may benefit from initial more aggressive resection.
METHODS: We identified 179 patients with Crohn's disease operated on for primary colonic disease. They were divided into segmental colectomy, total abdominal colectomy, and total proctocolectomy groups, based on their initial operation. They were further characterized by extent and location of colonic involvement. Long-term outcome variables evaluated included colonic and small-bowel surgical recurrences, postoperative complications and long-term sequelae, long-term need for medical therapy, and need for permanent fecal diversion.
RESULTS: Fifty-five patients underwent segmental colectomy, 49 total abdominal colectomy, and 75 total proctocolectomy. Patients with diffuse colonic involvement were significantly less likely to undergo segmental colectomy than total abdominal colectomy (P < 0.0001) or total proctocolectomy (P < 0.0001). Patients with distal involvement or pancolitis were significantly less likely to undergo segmental colectomy than total abdominal colectomy (P < 0.0001) or total proctocolectomy (P < 0.0001). Overall there were 31 patients (24.4 percent) with surgical Crohn's recurrences during follow-up: 19 (38.8 percent) in the segmental colectomy, 8 (22.9 percent) in the total abdominal colectomy, and 4 (9.3 percent) in the total proctocolectomy group. There was a significant difference in time to recurrence between the three groups by log-rank test (P = 0.017). Segmental colectomy patients had a significantly shorter time to first recurrence than total proctocolectomy patients (P = 0.014). After adjusting for extent of disease, the segmental colectomy group had a significantly greater risk of surgical recurrence than the total proctocolectomy group (P = 0.006). Total proctocolectomy patients were significantly less likely to be still taking medications one year after the index operation than total abdominal colectomy patients (P = 0.003) and segmental colectomy patients (P = 0.0003). During follow-up, patients with isolated distal disease were significantly more likely to require a permanent stoma than patients with isolated proximal disease (P = 0.004).
CONCLUSIONS: A more aggressive approach should be considered in patients with diffuse and distal Crohn's colitis. Total proctocolectomy in the properly selected patients is associated with low morbidity, lower risk of recurrence, and longer time to recurrence. Patients after total proctocolectomy are more likely to be weaned off all Crohn's-related medications. Long-term rate of permanent fecal diversion is significantly higher in patients with distal disease.

Entities:  

Mesh:

Year:  2005        PMID: 15785882     DOI: 10.1007/s10350-004-0906-3

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  32 in total

Review 1.  Surgical management of Crohn's disease.

Authors:  Virginia Oliva Shaffer; Steven D Wexner
Journal:  Langenbecks Arch Surg       Date:  2012-02-21       Impact factor: 3.445

2.  The role of hand-assisted laparoscopic surgery in subtotal and total colectomy for Crohn's colitis.

Authors:  Kiyokazu Nakajima; Riichiro Nezu; Masaki Hirota; Toshirou Nishida
Journal:  Surg Endosc       Date:  2010-04-07       Impact factor: 4.584

3.  Natural history of Crohn's disease following total colectomy and end ileostomy.

Authors:  Joanna Lopez; Gauree G Konijeti; Deanna D Nguyen; Jenny Sauk; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

4.  Local injection of infliximab in severe fistulating perianal Crohn's disease: an open uncontrolled study.

Authors:  L Alessandroni; A Kohn; R Cosintino; M Marrollo; C Papi; R Monterubbianesi; R Tersigni
Journal:  Tech Coloproctol       Date:  2011-10-20       Impact factor: 3.781

Review 5.  Surgery for inflammatory bowel disease.

Authors:  John M Hwang; Madhulika G Varma
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

6.  Risk of postoperative morbidity in patients having bowel resection for colonic Crohn's disease.

Authors:  Igors Iesalnieks; A Spinelli; M Frasson; F Di Candido; B Scheef; N Horesh; M Iborra; H J Schlitt; A El-Hussuna
Journal:  Tech Coloproctol       Date:  2018-12-12       Impact factor: 3.781

7.  Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk.

Authors:  Dine Koriche; Corinne Gower-Rousseau; Charbel Chater; Alain Duhamel; Julia Salleron; Noémie Tavernier; Jean-Frédéric Colombel; Benjamin Pariente; Antoine Cortot; Philippe Zerbib
Journal:  Int J Colorectal Dis       Date:  2016-11-24       Impact factor: 2.571

Review 8.  Colonic crohn disease.

Authors:  Traci L Hedrick; Charles M Friel
Journal:  Clin Colon Rectal Surg       Date:  2013-06

Review 9.  Surgery and diagnostic imaging in abdominal Crohn's disease.

Authors:  Fiorenzo Botti; Flavio Caprioli; Diego Pettinari; Alberto Carrara; Andrea Magarotto; Ettore Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-16

10.  Colonic Crohn's disease.

Authors:  Steven Mills; Michael J Stamos
Journal:  Clin Colon Rectal Surg       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.